Zonsen PepLib Biotech Inc. ("PepLib") today announced that it has entered a global research and development (R&D) collaboration and license agreement with Eli Lilly and Company ("Lilly"). Under the ...
Backed with $82 million and led by two of BioMarin’s former executives, Mendra plans to acquire rare disease assets and use ...
BOSTON, Nov. 06, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc., a biology-first, AI-powered, clinical-stage biopharma focused on mitochondrial biology and protein homeostasis, today announced it has won the ...
For biotech companies the past two years have been challenging. Biotech investments have not reached the record levels of ...
11m
Ensuring Purity and Performance: The Rise of Top Pharmaceutical and Electrochemical Manufacturers
HANGZHOU CITY, ZHEJIANG, CHINA, January 19, 2026 /EINPresswire.com/ -- With the development of the pharmaceutical and ...
The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...
Converge Bio, the AI platform for accelerated drug discovery and development, announced today $25 million in Series A funding, bringing its total raised to $30 million. The round was led by Bessemer ...
Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, and Qilu Pharmaceutical Group, a major comprehensive modern pharmaceutical enterprise in China, as well as its ...
Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...
MarketBeat on MSN
Biotech breakout: MoonLake up 30% on FDA wins
In a stock market currently obsessed with interest rate cuts and the artificial intelligence (AI) boom, it is easy to overlook the biotechnology sector. However, for investors willing to look beyond ...
China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...
67 WALL STREET, New York - September 14, 2012 - The Wall Street Transcript has just published its Biotechnology and Pharmaceuticals Report offering a timely review of the sector to serious investors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results